Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3690

Pharmaceutical Excipients Market by Type (Inorganic Chemicals (Calcium Phosphates, Calcium Carbonate, Calcium Sulfate, Halites, Metallic Oxides), Organic Chemicals (Carbohydrates, Petrochemicals)) and Function (Fillers and diluents, Binders, Coatings, Flavoring agents, Disintegrants, Colorants) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020

LI_161053
Pages: 116
Feb 2016 | 2663 Views
face gplus_n
Author's : Mohd. Adnan Malik
Tables: 58
Charts: 37
twit_n pr_n

Pharmaceuticals Excipients Market Overview:

Pharmaceuticals Excipients Market is expected to garner $6.4 billion by 2020, registering a CAGR of 7.6% during the forecast period 2015-2020. 

Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They also enhance the overall safety or functionality of the product during storage or use. The world pharmaceutical excipients market size is evaluated to reach 728.4 kilo tons in volume by 2020, accounting for a revenue of $6.4 billion.

The world pharmaceutical excipients market is driven by the increase in demand for oral solid pharmaceutical drugs and emergence of novel therapeutics on account of the upsurge in the number of pharmaceutical industries. The amalgamation of drug formulation and nanotechnology in excipients have led to the development of nano-coated tablets, nano-derived liposomes, and vaccines. In addition, several companies have targeted the emerging economies for expansion of their plants for manufacturing pharmaceutical excipients, preservatives, glycerin and Fatty Acids owing to cost-effective labor. However, higher production cost and stringent government regulations are likely to impede the overall growth. Applications including parenteral formulation, topical formulation and oral formulation are driving in huge investments. Moreover, the target audience consisting of reputed consulting firms, drug manufacturers, pharmaceutical excipients manufacturers, research & development companies will keep the future of the industry robust.

This report segments the world pharmaceutical excipients market on the basis of type, function, and geography. Based on type, the industry is segmented into organic and inorganic chemicals. Organic chemicals are further categorized into carbohydrates and petrochemicals. Based on function, the world market is classified into fillers and diluents, binders, coatings, flavoring agents, disintegrants, colorants, and others. The industry has been analyzed on the basis of regions, namely North America, Europe, Asia-Pacific, and LAMEA. The North America is the leading revenue-generating region, owing to growing demand for solid oral drugs for the treatment of chronic diseases. However, the Asia-Pacific region is expected to register the highest CAGR, owing to low cost of raw materials and availability of cost-effective workforce. The key companies profiled in this report include Ashland, Inc., BASF SE, Associated British Foods Plc, Akzo Nobel N.V., Evonik, Merck, J.M. Huber Corporation, Dow Chemicals Corporation, Merck Millipore, Croda International, and Archer Daniels Midland. These companies have adopted product launch as their key developmental strategy to expand their global presence.

KEY BENEFITS FOR STAKEHOLDERS:

  • The Pharmaceutical Excipients Market report offers an extensive study of the current trends along with the future market scenario across various geographies.
  • It provides detailed quantitative statistics of the current corporate structure and forecasts from 2014 to 2020 to identify the prevailing investment opportunities.
  • It delivers an in-depth analysis of the key driving and restraining factors of the market.
  • The key manufacturers of excipients have been profiled and their growth strategies are portrayed in a comprehensive format to outline the competitive landscape.
  • It offers detailed insights on new product launches and research and development activities taking place in the excipients industry.
  • SWOT analysis highlights the global positioning of leading manufacturers in the industry to formulate effective growth strategies.
  • The world pharmaceutical excipients market has been analyzed on the basis of regions to understand the regional trends across various geographies.

PHARMACEUTICAL EXCIPIENTS MARKET KEY SEGMENTS:

By Type

  • Inorganic Chemicals
    • Calcium Phosphates
    • Calcium Carbonate
    • Calcium Sulfate
    • Halites
    • Metallic Oxides
  • Organic Chemicals
    • Carbohydrates
      • Sugar
      • Starch
      • Cellulose
    • Petrochemicals
      • Glycols (alcohol)
      • Povidones polymers
      • Mineral Hydrocarbons
      • Oleochemicals
      • Gelatin (Proteins)

By Function

  • Fillers and diluents
  • Binders
  • Coatings
  • Flavoring agents
  • Disintegrants
  • Colorants
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
 

Chapter: 1 INTRODUCTION

1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology

1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2020

2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Government regulations

3.3.1 US-FDA perspective
3.3.2 EU EMEA perspective
3.3.3 Japan MHW perspective

3.4 Nanotechnology in excipient
3.5 Emerging role of excipients in the pharmaceutical industry
3.6 Porters five force analysis

3.6.1 Limited suppliers increase bargaining power
3.6.2 Lesser bargaining power of buyers due to intense competition
3.6.3 Lesser hazard from substitutes due to high fixed cost
3.6.4 Lesser threats from new entrants due to high capital investment
3.6.5 Superficial competition due to lesser global players

3.7 Value chain analysis
3.8 Patent analysis
3.9 Clinical trials

3.9.1 A study of insulin lispro with biochaperone excipients in healthy participants
3.9.2 Understanding typhoid disease after vaccination
3.9.3 Clinical trial no. 2 effect on acetaminophen metabolism by liquid formulations
3.9.4 Class 3 biowaivers
3.9.5 Phase 1 Norwalk vaccine study

3.10 Market dynamics

3.10.1 Drivers

3.10.1.1 Positive momentum of pharmaceutical industries
3.10.1.2 Impact of new excipients on the pharmaceutical industry
3.10.1.3 Diversified geographic market that reduces earnings

3.10.2 Restraints

3.10.2.1 Supply chain issues
3.10.2.2 SegregatedPHARMACEUTICAL EXCIPIENTS market that reduces earnings
3.10.2.3 Higher production cost
3.10.2.4 Stringent government regulations
3.10.2.5 Declining R&D investment

3.10.3 Opportunities

3.10.3.1 Opportunities in developing economies
3.10.3.2 New product development

Chapter 4 PHARMACEUTICAL EXCIPIENTS MARKET BY TYPE, 2014-2020

4.1 Overview

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast

4.2 Inorganic Chemicals

4.2.1 Market size and forecast
4.2.2 Calcium Phosphates

4.2.2.1 Market size and forecast

4.2.3 Calcium Carbonate

4.2.3.1 Market size and forecast

4.2.4 Calcium Sulfate

4.2.4.1 Market size and forecast

4.2.5 Halites

4.2.5.1 Market size and forecast

4.2.6 Metallic Oxides

4.2.6.1 Market size and forecast

4.2.7 Others

4.2.7.1 Market size and forecast

4.3 Organic chemicals

4.3.1 Market size and forecast
4.3.2 Carbohydrates

4.3.2.1 Market size and foreast
4.3.2.2 Sugars

4.3.2.2.1 MARKET SIZE AND FORECAST

4.3.2.3 Starch

4.3.2.3.1 MARKET SIZE AND FORECAST

4.3.2.4 Cellulose

4.3.2.4.1 MARKET SIZE AND FORECAST

4.3.3 Petrochemicals

4.3.3.1 Market size and forecast
4.3.3.2 Glycols (Alcohol)

4.3.3.2.1 MARKET SIZE AND FORECAST

4.3.3.3 Povidones Polymers

4.3.3.3.1 MARKET SIZE AND FORECAST

4.3.3.4 Mineral Hydrocarbons

4.3.3.4.1 MARKET SIZE AND FORECAST

4.3.3.5 Oleochemicals

4.3.3.5.1 MARKET SIZE AND FORECAST

4.3.3.6 Gelatin (Proteins)

4.3.3.6.1 MARKET SIZE AND FORECAST

Chapter 5 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2014-2020

5.1 Overview

5.1.1 Key market trends
5.1.2 Key growth factors and opportunities
5.1.3 Market size and forecast

5.2 Fillers & Diluents

5.2.1 Market size and forecast

5.3 Suspension & viscosity agents

5.3.1 Market size and forecast

5.4 Binders

5.4.1 Market size and forecast

5.5 Coatings

5.5.1 Market size and forecast

5.6 Flavoring agents

5.6.1 Market size and forecast

5.7 Disintegrants

5.7.1 Market size and forecast

5.8 Colorants

5.8.1 Market size and forecast

5.9 Others

5.9.1 Lubricants & Glidants

5.9.1.1 Role of lubricants

5.9.2 Preservatives
5.9.3 Market size and forecast

Chapter 6 PHARMACEUTICAL EXCIPIENTS MARKET BY GEOGRAPHY, 2014-2020

6.1 Overview
6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

Chapter 7 COMPANY PROFILES

7.1 Ashland Inc.

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Key strategies of Ashland Inc.

7.1.4.1 Primary Strategies: Product Launch
7.1.4.2 Secondary Strategies: Agreement

7.1.5 SWOT analysis of Ashland Inc.

7.2 Associated British Food Plc

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Key strategies of Associated British Food Plc

7.2.4.1 Primary Strategies: Product Launch
7.2.4.2 Secondary Strategies: Alliance

7.2.5 SWOT analysis of Associated British Food Plc

7.3 AkzoNobel

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Key strategies of AkzoNobel

7.3.3.1 Primary Strategies: Expansion
7.3.3.2 Secondary Strategies: acquisition

7.3.4 SWOT analysis of AkzoNobel

7.4 Evonik

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Key strategies of Evonik

7.4.4.1 Primary Strategies: Investments
7.4.4.2 Secondary Strategies: Expansion

7.4.5 SWOT analysis of Evonik

7.5 J.M. Huber Corporation

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Key strategies of J.M. Huber Corporation

7.5.3.1 Primary Strategies: expansion

7.5.4 SWOT analysis of J.M. Huber Corporation

7.6 Archer Daniels Midland

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Key strategies of Archer Daniels Midland

7.6.3.1 Primary Strategies: Product launch
7.6.3.2 Secondary Strategies: collaborations

7.6.4 SWOT analysis of Archer Daniels Midland

7.7 BASF

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Key strategies of BASF

7.7.3.1 Primary Strategies: Innovation
7.7.3.2 Secondary Strategies: acquisition

7.7.4 SWOT analysis of BASF

7.8 Dow Chemical Corporation

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Business performance
7.8.4 Key strategies of Dow Chemical Corporation

7.8.4.1 Primary Strategies: Collboration
7.8.4.2 Secondary Strategies: new product launches

7.8.5 SWOT analysis of Dow Chemical Corporation

7.9 Merck Millipore

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Business performance
7.9.4 Key strategies of Merck Millipore

7.9.4.1 Primary Strategies: Product Launch

7.9.5 SWOT analysis of Merck Millipore

7.10 Croda International plc

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Business performance
7.10.4 Key strategies of Croda International plc.

7.10.4.1 Primary Strategies: approval and expansion

7.10.5 SWOT analysis of Croda International plc.

List of Figures

FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2020-2025)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2020-2025)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 WORLD PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION
FIG. 5 TOP INVESTMENT POCKETS IN THE WORLD PHARMACEUTICAL EXCIPIENTS MARKET, 2014
FIG. 6 DISTRIBUTION OF TOP WINNING STRATEGIES
FIG. 7 PORTERS FIVE FORCE ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET
FIG. 8 VALUE CHAIN ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET
FIG. 9 PATENT ANALYSIS OF WORLD PHARMACEUTICAL EXCIPIENTS MARKET FROM 2014-2015
FIG. 10 TOP FACTORS IMPACTING WORLD PHARMACEUTICAL EXCIPIENTS MARKET, 2014-2020
FIG. 11 KEY FINANCIALS OF ASHLAND INC. BY GEOGRAPHY (2014)
FIG. 12 KEY FINANCIALS OF ASHLAND INC. BY REPORTABLE SEGMENTS (2014)
FIG. 13 SWOT ANALYSIS OF ASHLAND INC.
FIG. 14 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY GEOGRAPHY (2015)
FIG. 15 KEY FINANCIALS OF ASSOCIATED BRITISH FOOD PLC BY REPORTABLE SEGMENTS (2014)
FIG. 16 SWOT ANALYSIS OF ASSOCIATED BRITISH FOOD PLC
FIG. 17 KEY FINANCIALS OF AKZONOBEL BY GEOGRAPHY (2014)
FIG. 18 KEY FINANCIALS OF AKZONOBEL BY SEGMENTS (2014)
FIG. 19 SWOT ANALYSIS OF AKZONOBEL
FIG. 20 KEY FINANCIALS OF EVONIK BY BUSINESSES (2014)
FIG. 21 KEY FINANCIALS OF EVONIK BY SEGMENTS (2014)
FIG. 22 SWOT ANALYSIS OF EVONIK
FIG. 23 SWOT ANALYSIS OF J.M. HUBER CORPORATION
FIG. 24 KEY FINANCIALS OF ARCHER DANIELS MIDLAND BY BUSINESSES (2014)
FIG. 25 SWOT ANALYSIS OF ARCHER DANIELS MIDLAND
FIG. 26 KEY FINANCIALS OF BASF BY GEOGRAPHY (2014)
FIG. 27 KEY FINANCIAL OF BASF BY SALES BY REPORTABLE SEGMENTS (2014)
FIG. 28 SWOT ANALYSIS OF BASF
FIG. 29 KEY FINANCIALS OF DOW CHEMICAL CORPORATION BY GEOGRAPHY (2014)
FIG. 30 KEY FINANCIAL OF DOW CHEMICAL CORPORATION BY REPORTABLE SEGMENTS (2014)
FIG. 31 SWOT ANALYSIS OF DOW CHEMICAL CORPORATION
FIG. 32 FINANCIAL REVENUES OF MERCK MILLIPORE BY GEOGRAPHY (2014)
FIG. 33 FINANCIAL REVENUES OF MERCK MILLIPORE BY BUSINESS SEGMENT (2014)
FIG. 34 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 35 FINANCIAL REVENUES OF CRODA BY GEOGRAPHY (2014)
FIG. 36 FINANCIAL REVENUES OF CRODA BY BUSINESS SEGMENT (2014)
FIG. 37 SWOT ANALYSIS OF CRODA

List of Tables

TABLE 1 WORLD PHARMACEUTICAL EXCIPIENT BASE CASE SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 2 WORLD PHARMACEUTICAL EXCIPIENT BASE CASE SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 3 WORLD PHARMACEUTICAL EXCIPIENT RAPID GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 4 WORLD PHARMACEUTICAL EXCIPIENT RAPID GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 5 WORLD PHARMACEUTICAL EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET VOLUME, BY GEOGRAPHY, 2020-2025 (TONNES)
TABLE 6 WORLD PHARMACEUTICAL EXCIPIENT DIMINISHING GROWTH SCENARIO MARKET REVENUE, BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 7 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY TYPE, 2014-2020 (TONNES)
TABLE 8 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020 ($MILLION)
TABLE 9 WORLD INORGANIC CHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 10 WORLD CALCIUM PHOSPHATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 11 WORLD CALCIUM CARBONATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 12 WORLD CALCIUM SULFATE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 13 WORLD HALITES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 14 WORLD METALLIC OXIDES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 15 WORLD OTHERS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 16 WORLD ORGANIC CHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 17 WORLD CARBOHYDRATES EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 18 WORLD CARBOHYDRATES EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 19 WORLD SUGARS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 20 WORLD SUGARS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 21 WORLD CELLULOSE EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 22 WORLD PETROCHEMICAL EXCIPIENTS MARKET REVENUE, BY TYPE, 2014-2020, ($MILLION)
TABLE 23 WORLD PETROCHEMICAL EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 24 WORLD GLYCOLS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 25 FEATURES AND BENEFITS OF POVIDONES POLYMERS
TABLE 26 WORLD POVIDONE POLYMERS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 27 WORLD MINERAL HYDROCARBONS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 28 WORLD OLEOCHEMICALS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 29 WORLD GELATIN EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 30 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY FUNCTION, 2014-2020, (TONNES)
TABLE 31 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 32 WORLD FILLERS& DILUENTS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 33 WORLD SUSPENSION & VISCOSITY AGENTS EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 34 TYPES OF BINDERS USED AS EXCIPIENTS
TABLE 35 COMMON TYPE OF BINDERS USED IN THE MARKET
TABLE 36 WORLD BINDERS EXCIPIENTMARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 37 WORLD COATINGS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 38 WORLD FLAVORING AGENTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 49 WORLD DISINTEGRANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 40 WORLD COLORANTS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 41 WORLD OTHERS EXCIPIENT MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 42 WORLD PHARMACEUTICAL EXCIPIENTS MARKET VOLUME, BY GEOGRAPHY, 2014-2020, (TONNES)
TABLE 43 WORLD PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONS, 2014-2020, ($MILLION)
TABLE 45 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 46 ASIA PACIFIC EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 47 LAMEA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION, 2014-2020, ($MILLION)
TABLE 48 ASHLAND INC. COMPANY SNAPSHOT
TABLE 59 ASSOCIATED BRITISH FOOD PLC COMPANY SNAPSHOT
TABLE 50 AKZONOBEL COMPANY SNAPSHOT
TABLE 51 EVONIK COMPANY SNAPSHOT
TABLE 52 J.M. HUBER CORPORATION COMPANY SNAPSHOT
TABLE 53 ARCHER DANIELS MIDLAND COMPANY SNAPSHOT
TABLE 54 BASF COMPANY SNAPSHOT
TABLE 55 DOW CHEMICAL CORPORATION COMPANY SNAPSHOT
TABLE 56 SNAPSHOT OF MERCK MILLIPORE
TABLE 57 SNAPSHOT OF CRODA

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Pharmaceutical Excipients Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2020

  • Online Only
  • $3690
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts